APRIL CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Phase I Clinical Trial

被引：0
|
作者：
Li, Wenxiao [1 ,2 ,3 ,4 ]
Hu, Yongxian [1 ,2 ,4 ,5 ]
Zhang, Mingming [1 ,2 ,4 ,5 ]
Lai, Xinyi [1 ,2 ,4 ,5 ]
Zhao, Mengyu [1 ,2 ,4 ,5 ]
Fu, Shan [1 ,2 ,4 ,5 ]
Hong, Ruimin [1 ,2 ,4 ,5 ]
Chang, Alex H. [6 ]
Huang, He [1 ,2 ,4 ,7 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Sch Med, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sch Med, Liangzhu Lab, Hangzhou, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China
[4] Zhejiang Univ, Inst Hematol, Hangzhou, Peoples R China
[5] Zhejiang Prov Engn Res Ctr Stem Cell & Immun Thera, Hangzhou, Peoples R China
[6] Shanghai Yake Biotechnol Co Ltd, Shanghai, Peoples R China
[7] Zhejiang Prov Engn Res Ctr Stem Cell & Immun Thera, Hangzhou, Peoples R China
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-209660
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7229 / 7229
页数：1
相关论文
共 50 条
  • [21] Bispecific Antibodies Improve Outcomes in Patients With Relapsed or Refractory Multiple Myeloma After Car-T Cell Therapy
    Merz, Maximilan
    Dima, Danai
    Hashmi, Hamza
    Mueller, Fabian
    Ahmed, Nausheen
    Rathje, Kristin
    Davis, James
    Holderried, Tobias
    Vucinik, Vladan
    Kharbouti, Soraya
    Ayuk, Francis
    Stoelzel, Friedrich
    Schub, Natalie
    Schmitz, Friederike
    Shune, Leyla
    Khouri, Jack
    Anwer, Faiz
    McGuirk, Joseph
    Teichert, Marcel
    von Tresckow, Bastian
    Kroeger, Nicolaus
    Pabst, Thomas
    Abdallah, Al-Ola
    Gagelmann, Nico
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S73 - S74
  • [22] A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
    Mei, Heng
    Li, Chenggong
    Jiang, Huiwen
    Zhao, Xinying
    Huang, Zhiping
    Jin, Dan
    Guo, Tao
    Kou, Haiming
    Liu, Lin
    Tang, Lu
    Yin, Ping
    Wang, Zhihui
    Ai, Lisha
    Ke, Sha
    Xia, Yimeng
    Deng, Jun
    Chen, Lei
    Cai, Li
    Sun, Chunyan
    Xia, Linghui
    Hua, Gaoquan
    Hu, Yu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [23] A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
    Heng Mei
    Chenggong Li
    Huiwen Jiang
    Xinying Zhao
    Zhiping Huang
    Dan Jin
    Tao Guo
    Haiming Kou
    Lin Liu
    Lu Tang
    Ping Yin
    Zhihui Wang
    Lisha Ai
    Sha Ke
    Yimeng Xia
    Jun Deng
    Lei Chen
    Li Cai
    Chunyan Sun
    Linghui Xia
    Gaoquan Hua
    Yu Hu
    Journal of Hematology & Oncology, 14
  • [24] Failure of CAR-T cell therapy in relapsed and refractory large cell lymphoma and multiple myeloma: An urgent unmet need
    Martin, Yasmine St.
    Franz, Joseph K.
    Agha, Mounzer E.
    Lazarus, Hillard M.
    BLOOD REVIEWS, 2023, 60
  • [25] Strategies for salvage therapy post CAR-T therapy failure in refractory/relapsed multiple myeloma patients
    Min, Chao
    Zhong, Xiong
    Cui, Yue
    Zhang, Hanfu
    Wang, Qingming
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [26] CD27-Armored BCMA-CAR T Cell (CBG-002) Therapy for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
    Xu, Yang
    Zhang, Xuzhao
    Xin, Dijia
    Zhang, Jiawei
    Wang, Luyao
    Fan, Yili
    Chen, Boxiao
    Lei, Wen
    Qiu, Xi
    Jiang, Huawei
    Xiao, Xibin
    Huang, Liansheng
    Yang, Wenjun
    Zhu, Jiangao
    Qian, Wenbin
    BLOOD, 2023, 142
  • [27] CD27-Armored BCMA CAR T-cell Therapy (CBG-002) for Relapsed and Refractory Multiple Myeloma: A Phase I Clinical Trial
    Xu, Yang
    Zhang, Xuzhao
    Xin, Dijia
    Zhang, Jiawei
    Wang, Luyao
    Fan, Yili
    Chen, Boxiao
    Lei, Wen
    Qiu, Xi
    Jiang, Huawei
    Xiao, Xibin
    Huang, Liansheng
    Yu, Jiandong
    Yang, Xin
    Yang, Wenjun
    Zhu, Jiangao
    Qian, Wenbin
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (01) : 23 - 34
  • [28] A phase I study of anti-BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia
    Li, Chunrui
    Cao, Wenyue
    Que, Yimei
    Wang, Qiuxiang
    Xiao, Yi
    Gu, Chaojiang
    Wang, Di
    Wang, Jue
    Jiang, Lijun
    Xu, Hao
    Xu, Jinhuan
    Zhou, Xiaoxi
    Hong, Zhenya
    Wang, Na
    Huang, Liang
    Zhang, Shangkun
    Chen, Liting
    Mao, Xia
    Xiao, Min
    Zhang, Wei
    Meng, Li
    Cao, Yang
    Zhang, Tongcun
    Li, Jian
    Zhou, Jianfeng
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (03):
  • [29] Relapsed/Refractory Multiple Myeloma Patients. a Multicenter Retrospective Analysis of Eligibility Criteria for CAR-T Cell Therapy
    Fazio, Francesca
    Di Rocco, Alice
    Za, Tommaso
    Tomarchio, Valeria
    Rago, Angela
    Piciocchi, Alfonso
    di Toritto, Tommaso Caravita
    Annibali, Ombretta
    De Stefano, Valerio
    Foa, Robin
    Martelli, Maurizio
    Petrucci, Maria Teresa
    BLOOD, 2021, 138 : 3755 - +
  • [30] CAR-T cell therapy for relapsed or refractory multiple myeloma in 2024-clinically available treatment options in Austria
    Strassl, Irene
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2024, 17 (04) : 242 - 246
12345